Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.

Lassau N, Bonastre J, Kind M, Vilgrain V, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe-Devilliers C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Feutray S, Uzan-Augui J, Coiffier B, Benastou B, Koscielny S.

Invest Radiol. 2014 Dec;49(12):794-800. doi: 10.1097/RLI.0000000000000085.

2.

Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study.

Lassau N, Chapotot L, Benatsou B, Vilgrain V, Kind M, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Uzan-Augui J, Koscielny S.

Invest Radiol. 2012 Dec;47(12):711-6. doi: 10.1097/RLI.0b013e31826dc255.

PMID:
23095862
3.

Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab.

Lassau N, Coiffier B, Kind M, Vilgrain V, Lacroix J, Cuinet M, Taieb S, Aziza R, Sarran A, Labbe-Devilliers C, Gallix B, Lucidarme O, Ptak Y, Rocher L, Caquot LM, Chagnon S, Marion D, Luciani A, Feutray S, Uzan-Augui J, Benatsou B, Bonastre J, Koscielny S.

Ann Oncol. 2016 Oct;27(10):1922-8. doi: 10.1093/annonc/mdw280. Epub 2016 Aug 8.

4.

Study of Intrapatient Variability and Reproducibility of Quantitative Tumor Perfusion Parameters Evaluated With Dynamic Contrast-Enhanced Ultrasonography.

Lassau N, Coiffier B, Faivre L, Benatsou B, Bidault S, Girard E, Asselain B, Pitre-Champagnat S, Koscielny S.

Invest Radiol. 2017 Mar;52(3):148-154. doi: 10.1097/RLI.0000000000000324.

PMID:
28106614
5.
6.

Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.

Lassau N, Chami L, Koscielny S, Chebil M, Massard C, Benatsou B, Bidault S, Cioffi A, Blay JY, Le Cesne A.

Invest New Drugs. 2012 Apr;30(2):765-71. doi: 10.1007/s10637-010-9592-2. Epub 2010 Dec 7.

PMID:
21136137
7.

Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.

Pitre-Champagnat S, Leguerney I, Bosq J, Peronneau P, Kiessling F, Calmels L, Coulot J, Lassau N.

Invest Radiol. 2015 Apr;50(4):212-7. doi: 10.1097/RLI.0000000000000101.

PMID:
25275834
8.

Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy.

Williams R, Hudson JM, Lloyd BA, Sureshkumar AR, Lueck G, Milot L, Atri M, Bjarnason GA, Burns PN.

Radiology. 2011 Aug;260(2):581-90. doi: 10.1148/radiol.11101893. Epub 2011 May 9.

PMID:
21555352
9.

Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.

Lassau N, Koscielny S, Chami L, Chebil M, Benatsou B, Roche A, Ducreux M, Malka D, Boige V.

Radiology. 2011 Jan;258(1):291-300. doi: 10.1148/radiol.10091870. Epub 2010 Oct 27.

PMID:
20980447
10.

Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study.

McCarville MB, Coleman JL, Guo J, Li Y, Li X, Honnoll PJ, Davidoff AM, Navid F.

AJR Am J Roentgenol. 2016 May;206(5):933-9. doi: 10.2214/AJR.15.15789. Epub 2016 Mar 21.

11.

Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.

Pƶschinger T, Renner A, Eisa F, Dobosz M, Strobel S, Weber TG, Brauweiler R, Kalender WA, Scheuer W.

Invest Radiol. 2014 Jul;49(7):445-56. doi: 10.1097/RLI.0000000000000038.

PMID:
24598441
12.

Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results.

Frampas E, Lassau N, Zappa M, Vullierme MP, Koscielny S, Vilgrain V.

Eur J Radiol. 2013 May;82(5):e205-11. doi: 10.1016/j.ejrad.2012.12.004. Epub 2012 Dec 28.

PMID:
23273822
13.

Antiangiogenic tumor treatment: noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound.

Zhou J, Zheng W, Cao L, Liu M, Han F, Li A.

Acad Radiol. 2010 May;17(5):646-51. doi: 10.1016/j.acra.2010.01.008. Epub 2010 Mar 11.

PMID:
20223684
14.

Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US.

Sugimoto K, Moriyasu F, Saito K, Rognin N, Kamiyama N, Furuichi Y, Imai Y.

Liver Int. 2013 Apr;33(4):605-15. doi: 10.1111/liv.12098. Epub 2013 Jan 11.

PMID:
23305331
15.

Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.

Wang H, Hristov D, Qin J, Tian L, Willmann JK.

Radiology. 2015 Nov;277(2):424-34. doi: 10.1148/radiol.2015142824. Epub 2015 May 22.

16.

[Evaluation of early response to antiangiogenic treatment with dynamic contrast enhanced ultrasound].

Lassau N, Brule A, Chami L, Benatsou B, PĆ©ronneau P, Roche A.

J Radiol. 2008 May;89(5 Pt 1):549-55. Review. French.

PMID:
18535495
17.

Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.

Zhou J, Zhang H, Wang H, Lutz AM, El Kaffas A, Tian L, Hristov D, Willmann JK.

Angiogenesis. 2017 Nov;20(4):547-555. doi: 10.1007/s10456-017-9566-5. Epub 2017 Jul 18.

18.

Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.

Akisik MF, Sandrasegaran K, Bu G, Lin C, Hutchins GD, Chiorean EG.

Radiology. 2010 Aug;256(2):441-9. doi: 10.1148/radiol.10091733. Epub 2010 Jun 1.

PMID:
20515976
19.

Quantifying vascular heterogeneity using microbubble disruption-replenishment kinetics in patients with renal cell cancer.

Hudson JM, Williams R, Karshafian R, Milot L, Atri M, Burns PN, Bjarnason GA.

Invest Radiol. 2014 Feb;49(2):116-23. doi: 10.1097/RLI.0000000000000003.

PMID:
24220251
20.

Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment.

Lassau N, Chebil M, Chami L, Bidault S, Girard E, Roche A.

Target Oncol. 2010 Mar;5(1):53-8. doi: 10.1007/s11523-010-0136-7. Epub 2010 Apr 9. Review.

PMID:
20379790

Supplemental Content

Support Center